Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging. / Strindberg, Sophie; Plum, Jakob; Bagger, Charlotte; Janfelt, Christian; Müllertz, Anette.

In: Molecular Pharmaceutics, Vol. 18, No. 6, 2021, p. 2189–2197.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Strindberg, S, Plum, J, Bagger, C, Janfelt, C & Müllertz, A 2021, 'Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging', Molecular Pharmaceutics, vol. 18, no. 6, pp. 2189–2197. https://doi.org/10.1021/acs.molpharmaceut.0c01043

APA

Strindberg, S., Plum, J., Bagger, C., Janfelt, C., & Müllertz, A. (2021). Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging. Molecular Pharmaceutics, 18(6), 2189–2197. https://doi.org/10.1021/acs.molpharmaceut.0c01043

Vancouver

Strindberg S, Plum J, Bagger C, Janfelt C, Müllertz A. Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging. Molecular Pharmaceutics. 2021;18(6):2189–2197. https://doi.org/10.1021/acs.molpharmaceut.0c01043

Author

Strindberg, Sophie ; Plum, Jakob ; Bagger, Charlotte ; Janfelt, Christian ; Müllertz, Anette. / Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging. In: Molecular Pharmaceutics. 2021 ; Vol. 18, No. 6. pp. 2189–2197.

Bibtex

@article{7855bfd9885a4e9c9ca8fccfab813970,
title = "Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging",
abstract = "Mapping the spatial distribution of a drug throughout the gastrointestinal tract (GIT) after oral ingestion can provide novel insights into the interaction between the drug, the oral drug delivery system, and the GIT. Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) is a molecular imaging technique that can analyze molecules in the cryosections of tissues, determining their localization with a spatial resolution of 10-100 μm. The overall aim of this study was to use MALDI-MSI to visualize the distribution and spatial location of a model prodrug (fenofibrate) through the rat GIT. Furthermore, the distribution and spatial colocalization of taurocholate and phospholipids in the rat GIT in relation to fenofibrate were investigated. Rats were given a fenofibrate suspension of 10 mg/mL by oral gavage. Blood samples were drawn, and the rats were euthanized at three different time points. The GIT was collected and frozen, and MALDI-MSI was applied on cross sections of the stomach and intestine. Fenofibrate was detected by MALDI-MSI throughout the GIT, which also revealed that fenofibrate was hydrolyzed to the active drug fenofibric acid already in the stomach. Furthermore, the presence of lyso-phosphatidylcholine (lyso-PC) and taurocholate was confirmed in the lumen of the small intestine. MALDI-MSI was shown to be a useful qualitative tool for localizing parent prodrugs and active drugs, with a possibility for gaining insight into not only the location for activation but also the role of endogenous molecules in the process. ",
keywords = "bile salts, drug distribution, fenofibrate, in vivo, MALDI-MSI, mass spectrometry imaging, phospholipids, prodrug, tissue",
author = "Sophie Strindberg and Jakob Plum and Charlotte Bagger and Christian Janfelt and Anette M{\"u}llertz",
note = "Publisher Copyright: {\textcopyright} 2021 American Chemical Society.",
year = "2021",
doi = "10.1021/acs.molpharmaceut.0c01043",
language = "English",
volume = "18",
pages = "2189–2197",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "6",

}

RIS

TY - JOUR

T1 - Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging

AU - Strindberg, Sophie

AU - Plum, Jakob

AU - Bagger, Charlotte

AU - Janfelt, Christian

AU - Müllertz, Anette

N1 - Publisher Copyright: © 2021 American Chemical Society.

PY - 2021

Y1 - 2021

N2 - Mapping the spatial distribution of a drug throughout the gastrointestinal tract (GIT) after oral ingestion can provide novel insights into the interaction between the drug, the oral drug delivery system, and the GIT. Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) is a molecular imaging technique that can analyze molecules in the cryosections of tissues, determining their localization with a spatial resolution of 10-100 μm. The overall aim of this study was to use MALDI-MSI to visualize the distribution and spatial location of a model prodrug (fenofibrate) through the rat GIT. Furthermore, the distribution and spatial colocalization of taurocholate and phospholipids in the rat GIT in relation to fenofibrate were investigated. Rats were given a fenofibrate suspension of 10 mg/mL by oral gavage. Blood samples were drawn, and the rats were euthanized at three different time points. The GIT was collected and frozen, and MALDI-MSI was applied on cross sections of the stomach and intestine. Fenofibrate was detected by MALDI-MSI throughout the GIT, which also revealed that fenofibrate was hydrolyzed to the active drug fenofibric acid already in the stomach. Furthermore, the presence of lyso-phosphatidylcholine (lyso-PC) and taurocholate was confirmed in the lumen of the small intestine. MALDI-MSI was shown to be a useful qualitative tool for localizing parent prodrugs and active drugs, with a possibility for gaining insight into not only the location for activation but also the role of endogenous molecules in the process.

AB - Mapping the spatial distribution of a drug throughout the gastrointestinal tract (GIT) after oral ingestion can provide novel insights into the interaction between the drug, the oral drug delivery system, and the GIT. Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) is a molecular imaging technique that can analyze molecules in the cryosections of tissues, determining their localization with a spatial resolution of 10-100 μm. The overall aim of this study was to use MALDI-MSI to visualize the distribution and spatial location of a model prodrug (fenofibrate) through the rat GIT. Furthermore, the distribution and spatial colocalization of taurocholate and phospholipids in the rat GIT in relation to fenofibrate were investigated. Rats were given a fenofibrate suspension of 10 mg/mL by oral gavage. Blood samples were drawn, and the rats were euthanized at three different time points. The GIT was collected and frozen, and MALDI-MSI was applied on cross sections of the stomach and intestine. Fenofibrate was detected by MALDI-MSI throughout the GIT, which also revealed that fenofibrate was hydrolyzed to the active drug fenofibric acid already in the stomach. Furthermore, the presence of lyso-phosphatidylcholine (lyso-PC) and taurocholate was confirmed in the lumen of the small intestine. MALDI-MSI was shown to be a useful qualitative tool for localizing parent prodrugs and active drugs, with a possibility for gaining insight into not only the location for activation but also the role of endogenous molecules in the process.

KW - bile salts

KW - drug distribution

KW - fenofibrate

KW - in vivo

KW - MALDI-MSI

KW - mass spectrometry imaging

KW - phospholipids

KW - prodrug

KW - tissue

U2 - 10.1021/acs.molpharmaceut.0c01043

DO - 10.1021/acs.molpharmaceut.0c01043

M3 - Journal article

C2 - 33891424

AN - SCOPUS:85106440013

VL - 18

SP - 2189

EP - 2197

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 6

ER -

ID: 273634534